Curetis harnesses modern biochemistry and system engineering to automate molecular testing at the point of need, initially for rapid identification of bacteria and antibiotic resistances associated with severe acute infections. Its comprehensive solution delivers clinically relevant answers in only a few hours and repositions molecular testing for severe infectious diseases. The first application is for the rapid diagnosis of pneumonia. However, the universal solution allows expansion into other clinical applications, even for opportunities beyond infectious diseases.

With a team of seasoned hardware and software engineers, technical biologists, physicians, marketing experts, supply chain and manufacturing specialists as well as experienced Q&A and regulatory managers Curetis is well prepared to target the global IVD market. The team's expertise covers the entire cycle from the identification of clinically relevant measurements through product specification and design to manufacturing, marketing and commercialization. The cross-functional team works closely with Curetis' commercial, clinical and academic partners to best fulfill its customer needs. 

The certificate proves the successful implementation and use of a quality management system which conforms to the highest international quality management standard for medical devices, including in-vitro Diagnostics (IVD) products. This demonstrates Curetis commitment to quality and to developing safe and effective diagnostic products.